These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11223836)

  • 1. Pharmacokinetics of intraperitoneal oxaliplatin: experimental studies.
    Pestieau SR; Belliveau JF; Griffin H; Stuart OA; Sugarbaker PH
    J Surg Oncol; 2001 Feb; 76(2):106-14. PubMed ID: 11223836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model.
    Marchettini P; Stuart OA; Mohamed F; Yoo D; Sugarbaker PH
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):499-503. PubMed ID: 12107555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
    Pestieau SR; Stuart OA; Sugarbaker PH
    Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of intraperitoneal gemcitabine in a rat model.
    Pestieau SR; Stuart OA; Chang D; Jacquet P; Sugarbaker PH
    Tumori; 1998; 84(6):706-11. PubMed ID: 10080682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats.
    Mas-Fuster MI; Ramon-Lopez A; Lacueva J; Compañ A; Más-Serrano P; Nalda-Molina R
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):621-627. PubMed ID: 28168311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution.
    Elias D; Bonnay M; Puizillou JM; Antoun S; Demirdjian S; El OA; Pignon JP; Drouard-Troalen L; Ouellet JF; Ducreux M
    Ann Oncol; 2002 Feb; 13(2):267-72. PubMed ID: 11886004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
    Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of heated intraperitoneal oxaliplatin.
    Ferron G; Dattez S; Gladieff L; Delord JP; Pierre S; Lafont T; Lochon I; Chatelut E
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):679-83. PubMed ID: 18084764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body surface area predicts plasma oxaliplatin and pharmacokinetic advantage in hyperthermic intraoperative intraperitoneal chemotherapy.
    Leinwand JC; Bates GE; Allendorf JD; Chabot JA; Lewin SN; Taub RN
    Ann Surg Oncol; 2013 Apr; 20(4):1101-4. PubMed ID: 23456384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
    Los G; Mutsaers PH; Ruevekamp M; McVie JG
    Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats.
    Mas-Fuster MI; Ramon-Lopez A; Lacueva FJ; Arroyo A; Más-Serrano P; Nalda-Molina R
    Eur J Pharm Sci; 2018 Jul; 119():22-30. PubMed ID: 29626594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.
    Gesson-Paute A; Ferron G; Thomas F; de Lara EC; Chatelut E; Querleu D
    Ann Surg Oncol; 2008 Jan; 15(1):339-44. PubMed ID: 17943387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.
    Chalret du Rieu Q; White-Koning M; Picaud L; Lochon I; Marsili S; Gladieff L; Chatelut E; Ferron G
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):571-82. PubMed ID: 25053386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model.
    Piché N; Leblond FA; Sidéris L; Pichette V; Drolet P; Fortier LP; Mitchell A; Dubé P
    Ann Surg; 2011 Jul; 254(1):138-44. PubMed ID: 21494122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.
    Stewart JH; Shen P; Russell G; Fenstermaker J; McWilliams L; Coldrun FM; Levine KE; Jones BT; Levine EA
    Ann Surg Oncol; 2008 Aug; 15(8):2137-45. PubMed ID: 18493824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model.
    Jacquet P; Averbach A; Stuart OA; Chang D; Sugarbaker PH
    Cancer Chemother Pharmacol; 1998; 41(2):147-54. PubMed ID: 9443628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
    Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques.
    Ortega-Deballon P; Facy O; Jambet S; Magnin G; Cotte E; Beltramo JL; Chauffert B; Rat P
    Ann Surg Oncol; 2010 Jul; 17(7):1957-63. PubMed ID: 20143265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bevacizumab and hyperthermia in a rodent model of hyperthermic intraperitoneal chemotherapy (HIPEC).
    Verhulst J
    Int J Hyperthermia; 2013; 29(1):62-70. PubMed ID: 23311379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin for chemotherapeutic treatment and prevention of experimental peritoneal carcinomatosis in rats comparing the intraperitoneal and intravenous application mode.
    Hribaschek A; Meyer F; Ridwelski K; Kuester D; Lippert H
    Eur Surg Res; 2010; 44(2):74-81. PubMed ID: 20051689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.